Orion Porfolio Solutions, LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1360533
OMAHA, NE
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,136,711
+$138,418 QoQ
Shares Held
17,775
-14.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#123
of 264 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $26,666,840 across 17 Drug Manufacturers - Specialty & Generic names. KNSA ranks #8 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
123,571 | $5,070,118 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
26,926 | $4,538,108 | |
| 3 | HLN |
Haleon plc
|
478,177 | $4,461,391 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,176 | $2,262,682 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
110,838 | $1,776,733 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
15,254 | $1,692,278 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
52,791 | $1,299,186 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
17,775 | $1,136,711 |
All Filings in KNSA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,136,711 | 17,775 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $998,293 | 20,733 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $642,386 | 15,573 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $342,014 | 8,808 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||